Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Markus Leweke

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 18, 2012
Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjectsDivya Krishnamurthy, Laura W Harris, Yishai Levin, et al.
Analytical Biochemistry|January 2, 2007
Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometryDaniela Schreiber, Stephanie Harlfinger, Brit M Nolden, et al.
Translational Psychiatry|December 19, 2017
Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spotsJason D Cooper, Sureyya Ozcan, Renee M Gardner, et al.
Schizophrenia Research|February 27, 2018
Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patientsJakub Tomasik, Saskia L Smits, F Markus Leweke, et al.
JAMA Psychiatry|September 18, 2014
Oleoylethanolamide and human neural responses to food stimuli in obesityMartin Grosshans, Emanuel Schwarz, Jan Malte Bumb, et al.
Brain, Behavior, and Immunity|November 7, 2015
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patientsJakub Tomasik, Emanuel Schwarz, Santiago G Lago, et al.
Brain, Behavior, and Immunity|September 22, 2014
IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophreniaEmily G Severance, Kristin L Gressitt, Armin Alaedini, et al.
Brain, Behavior, and Immunity|October 9, 2017
Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patientsGeertje Frederique van Rees, Santiago Guillermo Lago, David Alan Cox, et al.
Journal of Proteome Research|June 29, 2010
Identification of N-glycosylation changes in the CSF and serum in patients with schizophreniaJohannes L Stanta, Radka Saldova, Weston B Struwe, et al.
Journal of Proteome Research|May 19, 2012
Antipsychotic treatment of acute paranoid schizophrenia patients with olanzapine results in altered glycosylation of serum glycoproteinsJayne E Telford, Jonathan Bones, Ciara McManus, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 18, 2012
Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjectsDivya Krishnamurthy, Laura W Harris, Yishai Levin, et al.
Analytical Biochemistry|January 2, 2007
Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometryDaniela Schreiber, Stephanie Harlfinger, Brit M Nolden, et al.
Translational Psychiatry|December 19, 2017
Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spotsJason D Cooper, Sureyya Ozcan, Renee M Gardner, et al.
Schizophrenia Research|February 27, 2018
Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patientsJakub Tomasik, Saskia L Smits, F Markus Leweke, et al.
JAMA Psychiatry|September 18, 2014
Oleoylethanolamide and human neural responses to food stimuli in obesityMartin Grosshans, Emanuel Schwarz, Jan Malte Bumb, et al.
Brain, Behavior, and Immunity|November 7, 2015
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patientsJakub Tomasik, Emanuel Schwarz, Santiago G Lago, et al.
Brain, Behavior, and Immunity|September 22, 2014
IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophreniaEmily G Severance, Kristin L Gressitt, Armin Alaedini, et al.
Brain, Behavior, and Immunity|October 9, 2017
Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patientsGeertje Frederique van Rees, Santiago Guillermo Lago, David Alan Cox, et al.
Journal of Proteome Research|June 29, 2010
Identification of N-glycosylation changes in the CSF and serum in patients with schizophreniaJohannes L Stanta, Radka Saldova, Weston B Struwe, et al.
Journal of Proteome Research|May 19, 2012
Antipsychotic treatment of acute paranoid schizophrenia patients with olanzapine results in altered glycosylation of serum glycoproteinsJayne E Telford, Jonathan Bones, Ciara McManus, et al.
Pageof 12